Solid Tumor Panel

GCG Solid Tumor Panel enables a more precise and targeted approach to patient care, ultimately improving treatment outcomes and patient survival rates.

What is the Solid Tumor Panel?

The solid tumor panel is a specialized genetic test that analyzes the genetic alterations present in various types of solid tumors, such as lung, breast, colon, and many others. This comprehensive test examines specific genes or genetic regions that are frequently mutated or altered in these types of cancers.

By utilizing advanced technologies like next-generation sequencing (NGS), the solid tumor panel provides a detailed understanding of the genetic makeup of the tumor cells, enabling healthcare providers to make informed treatment decisions and improve patient management.

The Necessity of the GCG Solid Tumor Panel

  1. Comprehensive Genetic Analysis:
    The solid tumor panel allows for a comprehensive genetic analysis of solid tumors, identifying specific mutations or alterations driving tumor growth. This information is vital for accurate diagnosis, prognosis, and treatment planning.

    • Genetic Alteration: The panel examines genetic alterations such as hotspot mutations, alterations in coding sequences (CDS), copy number variations (CNV), and RNA fusions.
    • Tumor Mutational Burden (TMB): TMB measures the total number of mutations in a tumor. High TMB indicates a higher likelihood of response to immune checkpoint inhibitors, enhancing treatment options.
    • Microsatellite Instability (MSI): MSI detects instability in short repetitive DNA sequences and identifies tumors that may respond well to immune checkpoint inhibitors.
  2. Personalized Treatment Options:
    By uncovering genetic mutations or alterations in the tumor, the solid tumor panel helps identify personalized treatment options. Targeted therapies or immunotherapies can be selected based on specific genetic variations, increasing the chances of a favorable treatment response.
  3. Prognostic and Predictive Information:
    The panel results provide essential prognostic and predictive information. They help estimate tumor aggressiveness, predict disease progression, and determine the potential response to different treatment modalities. This information assists in developing personalized treatment plans and monitoring treatment response.

Benefits of the Solid Tumor Panel

  1. Precision Treatment: The panel results guide healthcare providers in selecting treatments tailored to the specific genetic alterations found in the tumor, maximizing treatment effectiveness.
  2. Prognostic Information: The panel helps predict disease progression and provides valuable insights into the patient’s potential response to various treatment options.

How is the Test Performed?

The solid tumor panel requires a small tissue sample obtained through a biopsy or surgical procedure. This sample is then analyzed using advanced technologies like next-generation sequencing (NGS) to identify specific genetic alterations unique to the tumor.

The solid tumor panel plays a crucial role in personalized cancer care, offering valuable insights into the genetic characteristics of the tumor. By analyzing TMB and MSI status, the panel helps identify personalized treatment options and opens doors to innovative therapies. Consult with your healthcare provider to learn more about how the solid tumor panel can guide personalized cancer care, bringing hope for improved outcomes on the cancer journey.

How does GCG Solid Tumor Panel work?

Clear answers in just three simple steps.

Find out more about our test

Hereditary Cancer Panel

GCG Liquid Biopsy